Senior Peer Alliance for Rural Research On Wellness (SPARROW)
Case Management and Problem Solving Therapy for Depressed Older Adults
研究概览
详细说明
If you are eligible to participate in the study after completing the screening assessment, and if you choose to continue on, we will randomize you (like a flip of a coin) to receive either 12 weeks of case management combined with problem solving therapy (CM-PST) with a social worker or 12 weeks of self-guided problem solving therapy (SG-PST) with support from a senior peer counselor.
As part of your participation in the study you will participate in three 1.5 hour assessment interviews of psychological and neuropsychological functioning (similar to your screening assessment) prior to your first week of treatment (baseline), two weeks after your final session (week 14), and three months after your final session (week 24). Additionally, you will participate in three shorter assessment interviews of psychological functioning, which will be conducted at weeks 3 and 6. These assessments will take approximately 30-45 minutes.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
California
-
Sonora、California、美国、95370
- Catholic Charities Motherlode Office- Sonora
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Residence in rural Tuolumne, Calaveras, San Joaquin or Stanislaus Counties;
- Diagnosis: Major depression, unipolar (by SCID ascertained DSM-IV criteria);
- Severity of depression: A PHQ-9>10 or a 24-Item HDRS>19;
- Need for social services: CANE score> 2, i.e. at least one unmet need;
Exclusion Criteria:
- Psychotic depression by SCID-IV, i.e., presence of delusions;
- High suicide risk, i.e. intent or plan to attempt suicide in near future;
- Presence of any Axis I psychiatric disorder or substance abuse other than unipolar major depression;
- Axis II diagnosis of antisocial personality (by SCID-P and DSM-IV);
- History of psychiatric disorders other than unipolar major depression or generalized anxiety disorder (including bipolar disorder, hypomania, and dysthymia);
- Dementia: MMSE below 24 or clinical diagnosis of dementia by DSM-IV;
- Acute/severe medical illness (delirium, metastatic cancer, de-compensated cardiac, liver or kidney failure, stroke or myocardial infarction) 3 months prior to entry; or use of drugs causing depression, (steroids, reserpine, alphamethyl-dopa, tamoxiphen, vincristine);
- Inability to perform any of the ADLs (MAI: ADL subscale) even with assistance (walking with a cane is not an exclusion criterion)
- Inability to speak English;
- Aphasia interfering with communication;
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
---|---|
实验性的:CM-PST
If you are assigned to CM-PST, you will be working with the same care manager from your introductory session.
The care manager will continue to work with you on your problem-solving plan.
Additionally, you will receive case management services.
|
|
实验性的:SG-PST
If you are assigned to SG-PST, you will continue to work on your problem-solving plan, using the self-guided materials provided to you during the introductory session.
Additionally, you will be partnered with a senior peer counselor who will support you in your SG-PST efforts.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
---|---|---|
Hamilton Rating Scale for Depression (HRSD)
大体时间:Baseline
|
A multiple item questionnaire used to provide an indication of depression, and as a guide to evaluate recovery.
|
Baseline
|
Hamilton Rating Scale for Depression (HRSD)
大体时间:Week 3
|
A multiple item questionnaire used to provide an indication of depression, and as a guide to evaluate recovery.
|
Week 3
|
Hamilton Rating Scale for Depression (HRSD)
大体时间:Week 6
|
A multiple item questionnaire used to provide an indication of depression, and as a guide to evaluate recovery.
|
Week 6
|
Hamilton Rating Scale for Depression (HRSD)
大体时间:Week 12
|
A multiple item questionnaire used to provide an indication of depression, and as a guide to evaluate recovery.
|
Week 12
|
WHO Disability Assessment Schedule 2.0 (WHODAS-II)
大体时间:Week 0
|
Generic assessment instrument for health and disability
|
Week 0
|
WHO Disability Assessment Schedule 2.0 (WHODAS-II)
大体时间:Week 3
|
Generic assessment instrument for health and disability
|
Week 3
|
WHO Disability Assessment Schedule 2.0 (WHODAS-II)
大体时间:Week 6
|
Generic assessment instrument for health and disability
|
Week 6
|
WHO Disability Assessment Schedule 2.0 (WHODAS-II)
大体时间:Week 12
|
Generic assessment instrument for health and disability
|
Week 12
|
合作者和调查者
调查人员
- 首席研究员:Brooke Hollister, Ph.D.、University of California, San Francisco
- 首席研究员:Patricia Arean, Ph.D.、University of California, San Francisco
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- R01AG043584-01A1 (美国 NIH 拨款/合同)
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.
医学博士的临床试验
CM-PST的临床试验
-
Weill Medical College of Cornell UniversityNational Institute of Mental Health (NIMH)完全的
-
University of Illinois at ChicagoNational Institute on Alcohol Abuse and Alcoholism (NIAAA)招聘中
-
University of Illinois at ChicagoNational Institute of Mental Health (NIMH); Washington University School of Medicine; Stanford... 和其他合作者招聘中
-
University of OttawaOttawa Hospital Research Institute撤销
-
University of Texas at AustinBaylor College of Medicine; University of Kansas Medical Center完全的
-
University of Texas Southwestern Medical CenterHackensack Meridian Health; Kessler Institute for Rehabilitation; Baylor Health Care System完全的